Viking Therapeutics, Inc. (VKTX) Net Income (Loss) Attributable to Parent USD 2014 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Viking Therapeutics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2014 to 2024.
  • Viking Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending March 31, 2024 was -$27.4 M, a 40.1% decline year-over-year.
  • Viking Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending March 31, 2024 was -$93.7 M, a 29.6% decline year-over-year.
  • Viking Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$85.9 M, a 24.7% decline from 2022.
  • Viking Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$68.9 M, a 25.2% decline from 2021.
  • Viking Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$55 M, a 39.2% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$93.7 M -$27.4 M -$7.83 M -40.1% Jan 1, 2024 Mar 31, 2024 10-Q 2024-04-25
Q4 2023 -$85.9 M -$24.6 M -$5.05 M -25.8% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-07
Q3 2023 -$80.8 M -$22.5 M -$6.76 M -42.9% Jul 1, 2023 Sep 30, 2023 10-Q 2023-10-25
Q2 2023 -$74.1 M -$19.2 M -$1.79 M -10.3% Apr 1, 2023 Jun 30, 2023 10-Q 2023-07-26
Q1 2023 -$72.3 M -$19.5 M -$3.43 M -21.3% Jan 1, 2023 Mar 31, 2023 10-Q 2024-04-25
Q4 2022 -$68.9 M -$19.6 M -$7.2 M -58.3% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-07
Q3 2022 -$61.7 M -$15.8 M -$2.53 M -19.1% Jul 1, 2022 Sep 30, 2022 10-Q 2023-10-25
Q2 2022 -$59.1 M -$17.4 M -$2.05 M -13.3% Apr 1, 2022 Jun 30, 2022 10-Q 2023-07-26
Q1 2022 -$57.1 M -$16.1 M -$2.09 M -14.9% Jan 1, 2022 Mar 31, 2022 10-Q 2023-04-26
Q4 2021 -$55 M -$12.4 M -$1.41 M -12.9% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-07
Q3 2021 -$53.6 M -$13.2 M -$3.96 M -42.6% Jul 1, 2021 Sep 30, 2021 10-Q 2022-10-26
Q2 2021 -$49.6 M -$15.4 M -$5.81 M -60.7% Apr 1, 2021 Jun 30, 2021 10-Q 2022-07-27
Q1 2021 -$43.8 M -$14 M -$4.32 M -44.6% Jan 1, 2021 Mar 31, 2021 10-Q 2022-04-27
Q4 2020 -$39.5 M -$10.9 M -$3.5 M -47% Oct 1, 2020 Dec 31, 2020 10-K 2022-02-09
Q3 2020 -$36 M -$9.29 M -$3.56 M -62.1% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-03
Q2 2020 -$32.4 M -$9.57 M -$1.9 M -24.7% Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-28
Q1 2020 -$30.5 M -$9.69 M -$4.76 M -96.7% Jan 1, 2020 Mar 31, 2020 10-Q 2021-04-28
Q4 2019 -$25.8 M -$7.45 M -$2.21 M -42.2% Oct 1, 2019 Dec 31, 2019 10-K 2021-02-17
Q3 2019 -$23.6 M -$5.73 M +$869 K +13.2% Jul 1, 2019 Sep 30, 2019 10-Q 2020-10-28
Q2 2019 -$24.4 M -$7.67 M -$1 M -15% Apr 1, 2019 Jun 30, 2019 10-Q 2020-07-29
Q1 2019 -$23.4 M -$4.92 M -$1.37 M -38.7% Jan 1, 2019 Mar 31, 2019 10-Q 2020-04-30
Q4 2018 -$22.1 M -$5.24 M -$1.16 M -28.3% Oct 1, 2018 Dec 31, 2018 10-K 2020-02-26
Q3 2018 -$20.9 M -$6.6 M -$501 K -8.21% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-05
Q2 2018 -$20.4 M -$6.67 M -$1.5 M -29% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-01
Q1 2018 -$18.9 M -$3.55 M +$1.67 M +32% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-02
Q4 2017 -$20.6 M -$4.09 M -$440 K -12.1% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-13
Q3 2017 -$20.1 M -$6.1 M -$2.29 M -60.2% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-07
Q2 2017 -$17.8 M -$5.17 M -$1.48 M -40.1% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 -$16.4 M -$5.22 M -$1.64 M -45.6% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-09
Q4 2016 -$14.7 M -$3.64 M +$1.45 M +28.4% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-07
Q3 2016 -$16.2 M -$3.81 M +$929 K +19.6% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-08
Q2 2016 -$17.1 M -$3.69 M +$4.17 M +53% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-09
Q1 2016 -$21.3 M -$3.59 M +$2.12 M +37.2% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q4 2015 -$23.4 M -$5.09 M -$6.48 M -466% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-21
Q3 2015 -$16.9 M -$4.74 M -$4.47 M -1709% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-10
Q2 2015 -$12.4 M -$7.87 M +$14.9 M +65.5% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-11
Q1 2015 -$27.4 M -$5.71 M -$5.48 M -2395% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q4 2014 -$21.9 M $1.39 M Oct 1, 2014 Dec 31, 2014 10-K 2016-03-08
Q3 2014 -$262 K Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-05
Q2 2014 -$22.8 M Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-14
Q1 2014 -$229 K Jan 1, 2014 Mar 31, 2014 10-Q 2015-06-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.